-
EP2654787
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2654787
| EP2654787 - MODIFIED INFLUENZA HEMAGGLUTININ PROTEINS AND USES THEREOF [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 13.12.2013 Database last updated on 31.08.2024 | Most recent event Tooltip | 13.12.2013 | Withdrawal of application | published on 15.01.2014 [2014/03] | Applicant(s) | For all designated states Novavax, Inc. 9920 Belward Campus Drive Rockville, MD 20850 / US | [2013/44] | Inventor(s) | 01 /
SMITH, Gale c/o NOVAVAX INC. 9920 Belward Campus Drive Rockville Maryland 20850 / US | 02 /
LIU, Ye c/o NOVAVAX INC. 9920 Belward Campus Drive Rockville Maryland 20850 / US | 03 /
MASSARE, Michael c/o NOVAVAX INC. 9920 Belward Campus Drive Rockville Maryland 20850 / US | 04 /
SINGHVI, Rahul c/o NOVAVAX INC. 9920 Belward Campus Drive Rockville Maryland 20850 / US | [2013/44] | Representative(s) | Tollervey, Rebecca Marie, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
| Former [2013/44] | Tollervey, Rebecca Marie, et al Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB | Application number, filing date | 11849944.1 | 22.12.2011 | WO2011US66867 | Priority number, date | US201061426390P | 22.12.2010 Original published format: US 201061426390 P | [2013/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012088428 | Date: | 28.06.2012 | Language: | EN | [2012/26] | Type: | A1 Application with search report | No.: | EP2654787 | Date: | 30.10.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.06.2012 takes the place of the publication of the European patent application. | [2013/44] | Search report(s) | International search report - published on: | US | 28.06.2012 | Classification | IPC: | A61K39/145, C12N15/44 | [2013/44] | CPC: |
C12N7/00 (EP,KR);
A61K39/145 (KR);
A61P31/16 (EP);
A61P37/04 (EP);
C12N15/11 (KR);
A61K2039/5258 (EP);
A61K39/00 (EP,KR,US);
C12N2760/16122 (EP);
C12N2760/16123 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/44] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | MODIFIZIERTE INFLUENZA-HÄMAGGLUTININ-PROTEINE UND VERWENDUNGEN DAVON | [2013/44] | English: | MODIFIED INFLUENZA HEMAGGLUTININ PROTEINS AND USES THEREOF | [2013/44] | French: | PROTÉINES DE TYPE HÉMAGGLUTININE DU VIRUS DE LA GRIPPE MODIFIÉES ET LEURS UTILISATIONS | [2013/44] | Entry into regional phase | 09.07.2013 | National basic fee paid | 09.07.2013 | Search fee paid | 09.07.2013 | Designation fee(s) paid | 09.07.2013 | Examination fee paid | Examination procedure | 02.07.2013 | Amendment by applicant (claims and/or description) | 09.07.2013 | Examination requested [2013/44] | 06.12.2013 | Application withdrawn by applicant [2014/03] |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US2006216702 (COMPANS RICHARD W [US], et al); | [A]US2006263804 (ROBINSON ROBIN A [US], et al); | [Y]US2008014217 (HANON EMMANUEL JULES [BE], et al); | [X]WO2010006452 (MEDICAGO INC [CA], et al); | [Y]US2010184192 (SMITH GALE [US], et al) |